CSS
ACOR

Cubist Systematic Strategies’s Acorda Therapeutics ACOR Stock Holding History

Cubist Systematic Strategies’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-196
Closed -$22K – 2574
2020
Q1 		$22K Buy
196
+97
+98% +$19.1K ﹤0.01% 2062
2019
Q4 		$24K Sell
99
-215
-68% -$54.2K ﹤0.01% 2333
2019
Q3 		$108K Sell
314
-394
-56% -$214K ﹤0.01% 1926
2019
Q2 		$652K Sell
708
-475
-40% -$584K 0.01% 1308
2019
Q1 		$1.89M Buy
1,183
+1,027
+658% +$1.85M 0.06% 466
2018
Q4 		$292K Sell
156
-90
-37% -$196K 0.01% 1302
2018
Q3 		$579K Buy
246
+182
+284% +$563K 0.03% 738
2018
Q2 		$219K Sell
64
-435
-87% -$1.33M 0.01% 1293
2018
Q1 		$1.42M Buy
+499
New +$1.49M 0.08% 318
2017
Q2 		– Sell
-172
Closed -$433K – 1927
2017
Q1 		$433K Buy
172
+91
+112% +$262K 0.03% 717
2016
Q4 		$183K Buy
81
+20
+33% +$47.5K 0.01% 1298
2016
Q3 		$153K Sell
61
-45
-42% -$134K 0.01% 1361
2016
Q2 		$326K Sell
106
-19
-15% -$61.8K 0.02% 1034
2016
Q1 		$398K Sell
125
-169
-57% -$702K 0.02% 852
2015
Q4 		$1.51M Buy
294
+74
+34% +$323K 0.09% 314
2015
Q3 		$699K Buy
220
+151
+219% +$586K 0.04% 756
2015
Q2 		$276K Sell
69
-196
-74% -$757K 0.01% 1262
2015
Q1 		$1.06M Buy
265
+236
+814% +$1.08M 0.05% 539
2014
Q4 		$142K Sell
29
-75
-72% -$322K 0.01% 1622
2014
Q3 		$421K Buy
104
+62
+148% +$233K 0.03% 928
2014
Q2 		$171K Buy
+42
New +$171K 0.01% 1222

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cubist Systematic Strategies's ACOR Position: Q2 2020 in Review

Cubist Systematic Strategies sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 196 shares — an estimated $22K sold.

Cubist Systematic Strategies first reported a position in ACOR in Q2 2014 and held it in 21 quarters. The position peaked at $1.89M in Q1 2019. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Cubist Systematic Strategies reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Cubist Systematic Strategies sold 196 Acorda Therapeutics shares in Q2 2020, an estimated $22K.
  • Cubist Systematic Strategies first reported a position in Acorda Therapeutics in Q2 2014 and held it in 21 quarters.
  • Cubist Systematic Strategies's Acorda Therapeutics position peaked at $1.89M in Q1 2019.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Cubist Systematic Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.